FIRST AMERICAN HEALTH CONCEPTS INC
10QSB, 2001-01-11
BUSINESS SERVICES, NEC
Previous: WACHOVIA CORP/ NC, 424B3, 2001-01-11
Next: FIRST AMERICAN HEALTH CONCEPTS INC, 10QSB, EX-11.1, 2001-01-11



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

[X] Quarterly Report under Section 13 or 15(d) of the Securities
    Exchange Act of 1934.

    For the quarter ended October 31, 2000.

[ ] Transition Report under Section 13 or 15(d) of the Securities
    Exchange Act of 1934.

    For the transition period from    N/A    to    N/A   .
                                   ---------    ---------

                        Commission File Number: 0-15207


                      FIRST AMERICAN HEALTH CONCEPTS, INC.
              (Exact name of small business issuer in its charter)


      ARIZONA                                            86-0418406
(State of Incorporation)                    (IRS Employer Identification Number)


7776 South Pointe Parkway West, Suite 150, Phoenix, Arizona      85044-5424
       (Address of principal executive offices)                  (Zip Code)


                                 (602) 414-0300
                (Issuer's telephone number, including area code)


           SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:

                                      NONE

           SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:

                         Common Stock without par value
                                (Title of class)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Securities  Exchange  Act  during the past 12 months (or for
such shorter period that the registrant was required to file such reports),  and
(2) has been subject to such filing  requirements  for the past 90 days.
Yes [X] No [ ].

Registrant's  common stock  outstanding at January 1, 2001 was 2,604,736  shares
after deducting 468,102 shares of treasury stock.
<PAGE>
                                TABLE OF CONTENTS


PART I. FINANCIAL INFORMATION PAGE

     Item 1. Financial Statements (Unaudited)

          Consolidated Balance Sheet as of October 31, 2000                    2

          Consolidated Statements of Operations for the three months
          ended October 31, 2000 and 1999 (Restated)                           3

          Consolidated Statements of Cash Flows for the three months
          ended October 31, 2000 and 1999 (Restated)                           4

          Notes to the Consolidated Financial Statements                       5

     Item 2. Management's Discussion and Analysis of Financial Condition
             and Results of Operations                                        10

PART II. OTHER INFORMATION

     Item 4. Submission of Matters to a Vote of Security Holders Directors,
             Executive Officers, Promoters and Control Persons;               13

     Item 6. Exhibits and Reports on Form 8-K                                 13

Signatures                                                                    13
<PAGE>
                          PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                     CONSOLIDATED BALANCE SHEET (UNAUDITED)
                                OCTOBER 31, 2000


                                     ASSETS
Current assets:
 Cash and cash equivalents                                          $ 2,083,991
 Marketable investment securities                                       229,000
 Member fees receivable, net of an allowance of $322,082              1,352,254
 Deferred costs                                                         148,976
 Prepaid expenses                                                        93,558
 Deferred income taxes                                                  175,029
 Other current assets                                                   345,747
                                                                    -----------
        Total current assets                                          4,428,555
                                                                    -----------
Property and equipment:
 Office furniture and fixtures                                          325,372
 Computers and office equipment                                       4,011,005
 Leasehold improvements                                                 201,083
                                                                    -----------
                                                                      4,537,460

 Less accumulated depreciation and amortization                      (3,029,420)
                                                                    -----------
        Net property and equipment                                    1,508,040
                                                                    -----------

 Intangible assets, net                                                 763,376
                                                                    -----------

        Total assets                                                $ 6,699,971
                                                                    ===========

                      LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
 Accounts payable                                                   $   169,682
 Claims payable                                                         299,000
 Accrued expenses                                                       416,555
 Accrued income taxes                                                    30,877
 Deferred revenue                                                       870,290
                                                                    -----------
        Total current liabilities                                     1,786,404
                                                                    -----------

Commitments and contingencies                                                --

Shareholders' equity:
 Common stock, no par value; 8,000,000 shares authorized;
   3,072,838 shares issued                                              757,296
 Additional paid-in capital                                           2,550,795
 Retained earnings                                                    3,112,980
 Net unrealized loss on marketable investment securities                (21,772)
 Treasury stock, at cost, 468,102 shares                             (1,485,732)
                                                                    -----------
        Total shareholders' equity                                    4,913,567
                                                                    -----------

        Total liabilities and shareholders' equity                  $ 6,699,971
                                                                    ===========

          See accompanying notes to consolidated financial statements.

                                       2
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

<TABLE>
<CAPTION>
                                                                       THREE MONTHS ENDED
                                                                           OCTOBER 31,
                                                                  ----------------------------
                                                                     2000             1999
                                                                  -----------      -----------
                                                                                   (RESTATED)
<S>                                                               <C>              <C>
Operating revenues:
 Fee revenues                                                     $ 2,043,850      $ 1,689,433
 Reinsurance revenues                                               1,763,275          814,440
                                                                  -----------      -----------

        Total operating revenues                                    3,807,125        2,503,873

Operating expenses:
 Sales and marketing expenses                                         342,845          297,464
 Direct membership expenses                                           613,135          571,729
 General and administrative expenses                                  930,793          748,814
 Reinsurance expense                                                1,520,300          646,703
 Depreciation and amortization                                        141,133          135,972
 ESOP charges                                                          21,000            2,525
                                                                  -----------      -----------

        Total                                                       3,569,206        2,403,207
                                                                  -----------      -----------

        Operating income                                              237,919          100,666
                                                                  -----------      -----------
Non-operating income (expense):
 Interest income                                                       31,661           27,451
 Interest expense                                                          --             (448)
                                                                  -----------      -----------

        Total non-operating income                                     31,661           27,003
                                                                  -----------      -----------
        Net income before income tax expense and
         change in accounting principle                               269,580          127,669

Income tax expense                                                    (80,162)         (43,408)
                                                                  -----------      -----------

        Net income before change in accounting principle              189,418           84,261

Change in accounting principle, net of tax benefit of $95,337              --         (158,896)
                                                                  -----------      -----------

        Net income (loss)                                         $   189,418      $   (74,635)
                                                                  ===========      ===========
Basic and diluted net income (loss) per share:
 Net income before change in accounting principle                 $      0.07      $      0.03
 Change in accounting principle                                            --            (0.06)
                                                                  -----------      -----------

        Basic and diluted net income (loss) per share             $      0.07      $     (0.03)
                                                                  ===========      ===========
Basic weighted average common
 and equivalent shares outstanding                                  2,604,736        2,604,736
                                                                  ===========      ===========
Diluted weighted average common
 and equivalent shares outstanding                                  2,613,656        2,621,106
                                                                  ===========      ===========
</TABLE>

          See accompanying notes to consolidated financial statements.

                                       3
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
<TABLE>
<CAPTION>
                                                                        THREE MONTHS ENDED
                                                                            OCTOBER 31,
                                                                   ------------------------------
                                                                      2000               1999
                                                                   -----------        -----------
                                                                                       (RESTATED)
<S>                                                                <C>                <C>
Cash flows from operating activities:
 Net income (loss)                                                 $   189,418        $   (74,635)
 Adjustments to reconcile net income (loss) to
  net cash provided by (used in) operating activities:
  Change in accounting principle                                            --            158,896
  Depreciation and amortization                                        141,133            135,972
  ESOP shares committed to be released                                      --              2,525
  Provision for losses on accounts receivable                          (23,210)
  Deferred taxes                                                       (26,247)           (39,099)
 Changes in assets and liabilities:
  Member fees receivable                                               636,969            425,787
  Deferred costs                                                        (9,385)            (7,628)
  Prepaid expenses and other current assets                             95,752             57,557
  Income taxes receivable                                                   --            (57,319)
  Accounts payable                                                     (11,086)           (22,016)
  Claims payable                                                       (13,400)            17,000
  Accrued expenses                                                      80,717            (49,509)
  Accrued income taxes                                                 106,420                 --
  Deferred revenue                                                    (336,143)          (599,264)
                                                                   -----------        -----------

        Net cash provided by (used in) operating activities            830,938            (51,733)
                                                                   -----------        -----------
Cash flows from investing activities:
 Purchases of property and equipment                                   (31,843)           (49,125)
 Note receivable-officer                                                    --             28,794
                                                                   -----------        -----------

        Net cash used in investing activities                          (31,843)           (20,331)
                                                                   -----------        -----------

        Net increase (decrease) in cash and cash equivalents           799,095            (72,064)

Cash and cash equivalents, beginning of period                       1,284,896          1,625,874
                                                                   -----------        -----------

Cash and cash equivalents, end of period                           $ 2,083,991        $ 1,553,810
                                                                   ===========        ===========
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
 Cash paid during the period for taxes                             $    (2,150)       $   114,900
                                                                   ===========        ===========
 Cash paid during the period for interest                          $        --        $       458
                                                                   ===========        ===========
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING ACTIVITIES:
 Unrealized loss on marketable investment securities               $        --        $   (10,375)
                                                                   ===========        ===========
</TABLE>
          See accompanying notes to consolidated financial statements.

                                       4
<PAGE>
             FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


NOTE 1 - GENERAL

First American Health Concepts,  Inc. ("FAHC" or the "Company") was incorporated
in Arizona in 1981 and first offered common stock publicly in October 1985. FAHC
markets and administers vision care programs under the registered trade names of
Eye Care Plan of America(R) and ECPA(R).

Initially,  FAHC's growth came from the development of a direct access preferred
pricing program. This program is delivered through a national preferred provider
("PPO")   network  of  independent  and  retail   optometrists,   opticians  and
ophthalmologists.  The most  significant  growth  in the past  three  years  has
occurred  in  the  self-funded  products  and  the  insured  products  that  are
underwritten by primary insurance  carriers.  Prior to January 1998, the Company
received  administrative fee revenue in association with the insured revenue. In
January  1998,  FAHC  formed  a  captive  reinsurance  company,  First  American
Reinsurance  Company ("FARC") in order to share in the  underwriting  profits of
the primary carrier.

In December 1999,  the  subsidiary  Eye Care Plan of America - California,  Inc.
("ECPA-CA")  received licensure  approval from the state of California.  ECPA-CA
allows the  Company to operate as an HMO in the number one vision care market in
the country.  ECPA-CA operates as a specialized  Knox-Keene  Health Care Service
Organization.

PRINCIPLES OF CONSOLIDATION AND BASIS FOR PRESENTATION

These financial statements have been prepared by First American Health Concepts,
Inc. (the "Company") without audit, pursuant to the rules and regulations of the
Securities and Exchange Commission. In the opinion of the Company, the unaudited
consolidated  financial  statements include all adjustments  (consisting only of
normal  recurring   adjustments)  necessary  to  present  fairly  the  financial
position,  the  results  of  operations,  and  statements  of cash flows for the
periods presented.

The unaudited  consolidated  financial statements presented herein were prepared
using the underlying accounting principles utilized in the Company's fiscal year
2000 annual audited consolidated financial statements, filed on Form 10-KSB with
the Securities and Exchange  Commission on December 22, 2000.  Operating results
for the three months ended  October 31, 2000 are not  necessarily  indicative of
the results  that may be expected  for the year  ending July 31,  2001.  Certain
information,  accounting policies and footnote  disclosures normally included in
financial  statements  prepared in accordance with generally accepted accounting
principles have been omitted  pursuant to such rules and  regulations,  although
the Company  believes that the  disclosures are adequate to make the information
presented  not  misleading.   These  financial  statements  should  be  read  in
conjunction  with  the  Company's  audited  consolidated   financial  statements
included in the  Company's  Annual Report on Form 10-KSB for the year ended July
31, 2000.

The consolidated  financial  statements include the financial  statements of the
Company and its three wholly-owned  subsidiaries.  All significant  intercompany
balances and transactions have been eliminated in consolidation. As discussed in
Note 4, the Company restated its consolidated financial statements for the three
months  ended  October  31,  1999.  Accordingly,  amounts  included  within  the
footnotes for the three months ended October 31, 1999 have also been restated to
conform with that  presentation.  Additionally,  certain prior year amounts have
been  reclassified to conform to current year  presentation.  The effects of the
reclassifications had no impact on net income (loss).

                                       5
<PAGE>
             FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


NOTE 2 - EMPLOYEE STOCK OWNERSHIP PLAN

During fiscal 1994, the Company  implemented  an employee  stock  ownership plan
(First American Health Concepts,  Inc. Employee Stock Ownership Plan and related
Trust) (the "Plan"), qualified as a stock bonus plan under Section 401(a) of the
Internal Revenue Code. The Plan is designed to invest primarily in Company stock
exclusively for the benefit of eligible employees of the Company.  Each eligible
employee  becomes  a  participant  in the Plan  upon  completion  of one year of
service as defined by the Plan.  Company  contributions are determined each year
by the Company's  Board of Directors  (subject to certain  limitations)  and are
allocated  among the accounts of the  participants  in proportion to their total
compensation.

In October  1994,  the Trust  borrowed  $422,000  from a bank for a term of five
years  at an  annual  interest  rate of  8.42%.  The  proceeds,  along  with the
Company's 1994 ESOP  contribution,  were used to purchase 91,978 treasury shares
from the  Company.  Because  the Company had  guaranteed  the bank loan,  it was
reported as long term debt of the Company. The shares sold by the Company to the
Trust were reflected in shareholders' equity, and an amount corresponding to the
borrowing  (the  guaranteed  ESOP  obligation)  was  reported as a reduction  of
shareholders' equity.

The loan agreement required quarterly payments of principal and interest,  which
were paid from the Company's  contributions to the ESOP. As the principal amount
of the borrowing is repaid,  the liability and the  guaranteed  ESOP  obligation
were reduced.  The Company recognized  compensation expense equal to the average
fair market  value of the shares  committed  to be released  for  allocation  to
participants  in the ESOP,  which was based on total debt service  requirements.
The remaining principal balance of $21,100 was repaid during November 1999.

NOTE 3 - EARNINGS PER SHARE

The  following  is  presented  as a  reconciliation  of the  numerators  and the
denominators of basic and diluted earnings per share computations, in accordance
with SFAS No. 128.

<TABLE>
<CAPTION>
                                                         FOR THE THREE MONTHS ENDED OCTOBER 31,
                              ------------------------------------------------------------------------------------
                                               2000                                          1999
                              ----------------------------------------    ----------------------------------------
                                 INCOME         SHARES       PER SHARE    INCOME (LOSS)     SHARES       PER SHARE
                               (NUMERATOR)   (DENOMINATOR)    AMOUNTS      (NUMERATOR)   (DENOMINATOR)    AMOUNTS
                               -----------   -------------    -------      -----------   -------------    -------
<S>                            <C>           <C>             <C>          <C>            <C>             <C>
BASIC EPS:
 Income available to
  Common shareholders           $ 189,418      2,604,736       $0.07        $ 84,261       2,604,736      $ 0.03

 Change in accounting
  principle                                                                 (158,896)                      (0.06)

EFFECT OF DILUTIVE SECURITIES:
 Common stock options                              8,920                                      16,370
                                ---------     ----------       -----        --------       ---------      ------
DILUTED EPS:
 Income (Loss) available to
 Common shareholders            $ 189,418      2,613,656       $0.07        $(74,635)      2,621,106      $(0.03)
                                =========     ==========       =====        ========       =========      ======
</TABLE>

                                       6
<PAGE>
             FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


NOTE 4 - RESTATEMENT

During 2000,  subsequent to the initial  filing of the Company's form 10-QSB for
the three  months  ended  October  31,  1999,  several  accounting  errors  were
identified  that required  adjustment.  The Company  restated its Form 10-QSB on
June 20, 2000 to reflect those accounting adjustments.

On December 22, 2000,  the Company  filed its fiscal year 2000 annual  report on
Form 10-KSB,  which  included its  consolidated  financial  statements  covering
fiscal  years 2000 and 1999.  Prior to filing the fiscal year 2000 Form  10-KSB,
the Company  discovered  that several  additional  adjustments  were required to
correct the previously  restated  consolidated  financial  statements for fiscal
year  1999  which  were  originally   restated  and  filed  on  June  20,  2000.
Additionally,  the audit of fiscal year 2000 resulted in accounting adjustments;
some of which impacted the amounts  previously  reported in Form 10QSB/A for the
three months ended October 31, 1999.

The principal  reasons and  significant  effects of the original  restatement of
Form 10-QSB for the three  months ended  October 31, 1999,  the fiscal year 1999
restatements  and the fiscal year 2000 audit  adjustments  and their  collective
impact  on the  accompanying  consolidated  financial  statements  from  amounts
originally  reported in Form 10QSB for the three months  ended  October 31, 1999
are summarized as follows:

ORIGINAL RESTATEMENT OF FORM 10-QSB FOR THE THREE MONTHS ENDED OCTOBER 31, 1999

UNRECORDED CLAIMS RESERVE

In  January  1998,  the  Company  formed  a  captive  reinsurance  company  with
operations  commencing in early 1999. The Company  determined that it had failed
to accurately  accrue a liability for "incurred but not reported" insured claims
in the period in which they were incurred. Accordingly,  reinsurance expense for
the  three  months  ended  October  31,  1999 was  increased  by  $17,000  and a
corresponding liability was recorded.

DEFERRED COSTS

Subsequent  to the filing of the Form 10-QSB for the three months ended  October
31, 1999, management determined that certain member costs deferred and amortized
over the life of the renewal  premiums were in fact period costs and should have
been charged to expense as incurred. In evaluating both the capitalized deferred
cost  balances in years prior to 1999,  as well as the total cost  amortized  to
expense in those years, all amounts were comparable and the amounts  capitalized
were consistent from period to period.  Correspondingly,  the Company originally
restated its  financial  statements  to reflect  these costs  retroactively  and
record the expense as incurred. Accordingly,  deferred member costs were reduced
by $14,969 at October 31, 1999 and recorded as expense for the quarter.

CHANGE IN ACCOUNTING PRINCIPLE

The Company adopted SOP 98-5, REPORTING THE COSTS OF START-UP ACTIVITIES, in the
quarter ended October 31, 1999.  Subsequent to the filing of the Form 10-QSB for
the three months  ended  October 31, 1999,  management  determined  that the tax
benefit of the  write-off  of deferred  organizational  costs was not  correctly
determined.  Accordingly,  the change in  accounting  principle  was  reduced by
$85,000 to  correctly  reflect the change in  accounting  principle,  net of the
appropriate  amount of taxes, and a corresponding tax receivable was recorded to
recognize the asset in the period it was realized.

                                       7
<PAGE>
             FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


RESTATEMENT OF FISCAL YEAR 1999

As referred to above, the consolidated financial statements for fiscal 1999 were
further  restated  and are  included  in the  Company's  fiscal year 2000 Annual
Report on Form 10KSB  filed on December  22,  2000.  The  overall  effect on the
consolidated  financial  statements as of and for the three months ended October
31, 1999 resulting from the fiscal year 1999  restatements  reduced total assets
by $1,299,900 and total equity by $1,037,414.

AUDIT OF FISCAL YEAR 2000

The audit of fiscal year 2000  resulted in  additional  accounting  adjustments;
some of which impacted the amounts  previously  reported on Form 10QSB/A for the
three months  ended  October 31, 1999.  The impact of these  adjustments  are as
follows:

REVENUE RECOGNITION

During fiscal year 2000, the Company failed to reconcile, on a timely basis, the
detailed activity of its customer accounts receivable to the general ledger. The
reconciliation process revealed that various of its customers' account histories
did not properly account for billings, billing adjustments and/or bad debts that
should  have been  reflected  in the  periods  in which  they were  incurred  or
realized. Accordingly, revenues for the three months ended October 31, 1999 have
been reduced by $33,404,  resulting from accounting errors, to correctly reflect
revenue  in the  period  realized  and a  corresponding  reduction  in  accounts
receivable was recorded.

CHANGE IN ACCOUNTING PRINCIPLE

The Company adopted SOP 98-5, REPORTING THE COSTS OF START-UP ACTIVITIES, during
the three months ended October 31, 1999.  The Company was  previously  deferring
start-up costs associated with its California  subsidiary.  ECPA-CA now operates
as a Specialized  Knox-Keene Health Care Services  Organization  licensed by the
California  Department of  Corporations.  Included  within  deferred  costs were
expenditures  associated  with obtaining its Knox-Keene  license which qualified
for capitalization as an intangible asset. Thus $779,618 of costs,  $483,363 net
of tax,  originally  recorded  as  expense  within  the  "change  in  accounting
principle"  during the three months ended October 31, 1999, has been capitalized
as an intangible asset.

The overall affect of the  restatements  resulting from the audit of fiscal year
2000 on the  consolidated  financial  statements  as of and for the three months
ended  October 31, 1999  increased  total assets by $869,461 and reduced the net
loss by $461,316 or $0.18 per share, basic and diluted.

                                       8
<PAGE>
             FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


SUMMARY

The affects of the  restatements on the consolidated  financial  statements from
the amounts  that were  originally  reported on Form 10QSB for the three  months
ended October 31, 1999 are as follows:

       Total assets:
         Originally reported                                         $6,411,792
         Restated                                                    $5,981,383

       Total Equity:
         Originally reported                                         $5,389,644
         Restated                                                    $4,813,546

       Net income before change in accounting principle:
         Originally reported                                         $  243,903
         Restated                                                    $   84,261

       Net loss:
         Originally reported                                         $ (573,158)
         Restated                                                    $  (74,635)

       Net income per share before change in accounting
       principle (basic and diluted):
         Originally reported                                         $     0.06
         Restated                                                    $     0.03

       Net loss per share (basic and diluted):
         Originally reported                                         $    (0.22)
         Restated                                                    $    (0.03)

                                       9
<PAGE>
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
        AND RESULTS OF OPERATIONS

     The Management's Discussion and Analysis of Financial Condition and Results
of  Operations  for the three  months  ended  October 31, 1999  presented  below
reflects certain  restatements to the Company's  previously  reported results of
operations.  See Note 4 of the notes to  consolidated  financial  statements for
discussions of these restatements.

RESULTS OF OPERATIONS

     Net income,  before  change in accounting  principle,  for the three months
ended  October 31,  2000 was  $189,000,  or $0.07 per share  basic and  diluted,
compared to net income,  before change in accounting  principle,  of $84,000, or
$0.03 per share basic and  diluted,  for the same period a year ago.  Net Income
for the three months ended October 31, 2000 significantly  increased as a result
of an increase in insured and self-funded revenue which was due to a significant
increase in the volume of insured  customers  marketed  through  the  Company's
captive  reinsurance  subsidiary.  Net income for the three months ended October
31, 1999 was reduced by  $159,000,  net of taxes of $95,000,  or $0.06 per share
basic and diluted,  due to a change in accounting  principle  resulting from the
Company's  adoption of  Statement  of Position  98-5 which  requires  that costs
incurred during start-up activities,  including  organization costs, be expensed
as  incurred.  Net  income  for the three  months  ended  October  31,  2000 was
$189,000,  or $0.07 per share  basic and  diluted.  After  giving  effect to the
change in  accounting  principle,  net income for the three months ended October
31,  1999 was  reduced to a net loss of  $75,000,  or $0.03 per share  basic and
diluted.

     Operating  revenues for the three months ended  October 31, 2000  increased
$1,303,000 or 52% to  $3,807,000  from  $2,504,000  for the same period in 1999.
Non-insured  products  decreased  $15,000  or 1% to  $925,000,  as  compared  to
$940,000 for the same period in 1999.  This decrease is a reflection of changing
market demand for vision care preferred pricing or "discount"  programs that the
Company has been anticipating for several years. Insured and self-funded product
revenues  increased  $1,032,000 or 91% to $2,171,000,  as compared to $1,139,000
for the same period in 1999. The significant increase in insured and self-funded
revenue was due to a  significant  increase  in the volume of insured  customers
marketed through the Company's captive  reinsurance  subsidiary.  Other revenues
increased  $285,000 or 67% to  $711,000,  as  compared to $426,000  for the same
period in 1999.  The  significant  increase in other revenues was due to various
administrative and marketing services provided to the Company's carriers through
its captive  reinsurance  subsidiary,  as well as an increase in new self-funded
clients.   Market   research   continues  to  show  an  increasing   demand  for
full-benefit,  managed  vision  care  programs.  The  Company  anticipates  that
revenues from its managed vision care programs  (insured and  self-funded)  will
continue to be the source of growth in the future.  This is the reason that FARC
was formed in January 1998.  FARC assumes a portion of the insured  premium from
the underwriting  carrier through a Quota Share  agreement.  The premium assumed
under  this  agreement  during  the three  months  ended  October  31,  2000 was
$1,763,000 of the insured and self-funded  revenues discussed above, as compared
to $814,000 for the same period in 1999.

     Total  operating  expenses  for the three  months  ended  October  31, 2000
increased  $1,166,000  or 49% for the three  months  ended  October  31, 2000 to
$3,569,000,  as compared to $2,403,000 for the same period in 1999. However, the
ratio of total operating expenses to total revenue decreased to 94%, as compared
to 96% for the same period in the prior year.  The  majority of the  increase in
operating  expenses  resulted  from an increase  in  reinsurance  expense  which
corresponds with the increase in reinsurance premium revenue.  Overall operating
expenses as a  percentage  of  operating  revenues  are  expected to continue to
decrease as the Company continues to increase its volume of activity through its
reinsurance subsidiary.

                                       10
<PAGE>
     Sales and  marketing  costs  increased  $46,000 or 15% to $343,000  for the
three months ended  October 31, 2000,  as compared to $297,000 for the period in
the prior year. The increase is due to sales and marketing  salaries,  brokerage
commissions  and a slight  increase in travel related  expenses all of which are
attributable to continued increased sales marketing efforts. The Company expects
that sales and  marketing  expenses  will  continue  to  increase  in the future
commensurate  with  its  anticipated  growth  in  its  insured  and  self-funded
products.

     Direct membership costs,  those costs associated with supplying vision plan
members with membership  materials,  maintaining a national locator service, and
administering  claims processing  functions  increased $41,000 or 7% to $613,000
for the three  months ended  October 31,  2000,  as compared to $572,000 for the
same period in the prior year.  The  increase in direct  member  costs is due to
higher payroll as a result of increased  staffing needs offset by a reduction in
contract labor and lower printing and postage expenses.

     General and  administration  expenses ("G&A") increased  $182,000 or 24% to
$931,000 for the three months  ended  October 31, 2000,  as compared to $749,000
for the same  period  in the prior  year.  G&A  increased  as a result of higher
salary  and  related  benefits,  costs of  opening  five new sales  offices  and
increased  professional  services costs attributable to the fiscal year 2000 and
1999 restatements offset by lower contract labor and travel related expenses.

     Reinsurance  expense increased $874,000 or 135% to $1,520,000 for the three
months  ended  October 31,  2000,  as compared to $646,000  for the three months
ended October 31, 1999.  The increased  expense  corresponds  to the increase in
reinsurance revenues.

     Depreciation  and  amortization  was  $141,000  for the three  months ended
October 31, 2000,  as compared to $136,000 for the  corresponding  period in the
prior year. The slight  increase was due to the  amortization  of the Knox-Keene
license which was granted in late December 1999. There was no such  amortization
during the three months ended October 31, 1999.

     ESOP  compensation  expense  represents  contributions  committed  for  the
periods  in  accordance  with  the  Company's   employee  stock  ownership  plan
implemented during fiscal 1994. Contributions to the ESOP plan are discretionary
and considers the profitability of the Company.  ESOP expense recognized is also
affected by  compensation  expense of eligible  participating  employees and the
average market price of the Company's common stock during the quarter.

     Interest  income was $32,000 for three  months ended  October 31, 2000,  as
compared  to $27,000  for the  corresponding  period in 1999.  The  increase  in
interest  income is due to higher  weighted  average amount of invested funds as
compared to the prior year.

     Interest  expense  decreased  due to the ESOP loan  being  fully  repaid in
November 1999.

                                       11
<PAGE>
LIQUIDITY AND CAPITAL RESOURCES

     Working  capital  increased 13% from $2,343,000 and a current ratio of 2.15
to 1 at July 31, 2000 to working  capital of  $2,642,000  and a current ratio of
2.48 to 1 at  October  31,  2000.  Cash  and  cash  equivalents  and  marketable
investment securities increased $799,000 or 53% from $1,514,000 at July 31, 2000
to $2,313,000 at October 31, 2000.

     The  Company's  cash and cash  equivalents  increased  $799,000 or 62% from
$1,285,000 at July 31, 2000 to  $2,084,000  at October 31, 2000.  Cash flow from
operating  activities  was $831,000 for the three months ended  October 31, 2000
compared to cash used in operating  activities  of $(52,000) for the same period
in 1999. The  significant  increase in cash flows from operating  activities for
the three months ended October 31, 2000 was due to a focus on collection efforts
of past due  accounts  and due to the  significant  increase  in the  volume  of
insured customers marketed through the Company's captive reinsurance  subsidiary
which  accounted  for the  majority  of the  increase in overall  earnings.  The
majority of the  Company's  use of funds for the three months ended  October 31,
2000 and  1999 was the  purchase  of new  computer  hardware  and  software  and
necessary system implementation support.

     Management  anticipates  moderate capital expansion in 2001 through capital
additions and  infrastructure  expenditures to accommodate  growth as it occurs.
The Company believes its ongoing cash flow will support all anticipated  capital
expenditures and operating expenses.

SUBSTANTIAL PROFESSIONAL SERVICES EXPENSES

     The Company has incurred  substantial  costs in connection with the process
of reviewing, reconciling and restating its books and records, the investigation
of its prior  accounting  practices and preparation of its audited  consolidated
financial  statements for the years ended July 31, 2000 and 1999 included in its
annual  report on Form 10KSB  filed on  December  22,  2000.  Included  in these
expenses are the costs of the audits for fiscal year 2000 and 1999, legal costs,
and costs of retaining  outside  accounting  assistance to assist  management in
reviewing and reconciling its books and records.  Total cost incurred to date is
$241,000  of which  $48,000  has been  expensed  during the three  months  ended
October  31,  2000.   Management   estimates  that  an  additional  $143,000  of
professional  service  costs will be incurred  to complete  the fiscal year 2000
review which will be expensed during the second quarter of fiscal 2001.

CHANGE IN ACCOUNTING PRINCIPLE

     The Company adopted Statement of Position ("SOP") 98-5 "REPORTING THE COSTS
OF START-UP  ACTIVITIES"  which  requires that costs  incurred  during  start-up
activities,  including  organization  costs,  be expensed as incurred.  This new
standard, which was effective for the Company for the fiscal year ended July 31,
2000, was evaluated by management  and any relevant  costs were expensed  during
the quarter  ended  October 31,  1999.  The  Company  was  previously  deferring
start-up costs  associated  with ECPA-CA.  Accordingly,  the Company  recorded a
$159,000  change in accounting  principle  (after  reduction for income taxes of
$95,000)  which is included in the net loss for the three months  ended  October
31, 1999.  This change in  accounting  principle  resulted in a reduction of net
income per share of $0.06 per share basic and diluted.

                                       12
<PAGE>
FORWARD-LOOKING STATEMENTS

     This report on Form 10-QSB contains forward-looking  statements.  The words
"believe,"  "expect,"  "anticipate,"  and  "project,"  and  similar  expressions
identify  forward-looking  statements,  which  speak  only  as of the  date  the
statement was made.  Such  forward-looking  statements are within the meaning of
that term in Section 27A of the Securities Act of 1933, as amended,  and Section
21E of the  Securities  Exchange Act of 1934, as amended.  Such  statements  may
include,  but are not limited to,  projections  of  revenues,  income,  or loss,
capital expenditures, plans for future operations, financing needs or plans, the
impact of inflation and plans relating to the foregoing.

                           PART II. OTHER INFORMATION

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     None

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

     Item 6(a)   Exhibit 11.1 -- Computation of Per Share Earnings

     Item 6(b)   No reports on Form 8-K have been filed during the quarter for
                 which this report is filed.

                                       13
<PAGE>
                                   SIGNATURES

     In accordance with Section 13 or 15 (d) of the Exchange Act, the registrant
has caused this report to be signed on its behalf by the undersigned,  thereunto
duly authorized.

                                    FIRST AMERICAN HEALTH CONCEPTS, INC.
                                               (Registrant)


Date: January 12, 2001              By: /s/ James D. Hyman
                                       -------------------------------------
                                       James D. Hyman
                                       President and Chief Executive Officer

         In accordance  with the Exchange Act, this report has been signed below
by the following  persons on behalf of the  registrant and in the capacities and
on the dates indicated.

     SIGNATURE                            TITLE                           DATE
     ---------                            -----                           ----


/s/ James D. Hyman            President and Chief Executive Officer      1/11/01
---------------------------
   James D. Hyman



/s/ James A. Gresko           Vice President Finance and                 1/11/01
---------------------------   Chief Financial Officer
   James A. Gresko

                                       14


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission